A carregar...
Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn’s Disease
Treatment with Anti-Tumor Necrosis Factor (anti-TNF) therapy has become a mainstay of therapy for patients with CD who are unresponsive to conventional medical management. Currently there are three anti-TNFα antibodies that have been approved by the US Food and Drug Administration for the treatment...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Libertas Academica
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3987757/ https://ncbi.nlm.nih.gov/pubmed/24833930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CGast.S7613 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|